Led · Seed · Jun 2018

LifeSprout is a Baltimore-based regenerative medicine company that licensed technology from Johns Hopkins University. It has developed a proprietary Regenerative Matrix platform comprising biomimetic, biocompatible materials engineered to look and feel like natural tissue. The first product, Lumina™, is a next-generation aesthetic filler that combines the proven safety of hyaluronic acid with biostimulatory effects. The company is also developing additional cell therapy products intended to offer regenerative solutions, including treatments for patients with orphan diseases. LifeSprout closed a $28.5M Series A financing and intends to use the proceeds for clinical development of novel therapeutic products from its Regenerative Matrix platform. The company is led by co-founder Sashank Reddy, MD, PhD, with Adam Gridley serving as Executive Chairman. LifeSprout is developing a synthetic material designed to provide space for the body to regenerate its own soft tissue over time. The company aims to bring its soft tissue replacement technology to market for applications such as reconstruction after trauma or disease. Leadership includes CEO Sashank Reddy and founders Russell Martin, Hai‑Quan Mao, Justin Sacks and Sashank Reddy. The startup recently closed a financing round to support development and commercialization efforts. The article does not disclose operating metrics such as revenue or user counts.